Concepedia

Michael Pourdehnad

MP

Statistics

Publications

37

Citations

3.5K

H-Index

22

Active since

1999

Affiliations

Bristol-Myers Squibb (United States)(Current)

Hospital of the University of Pennsylvania

The University of Texas MD Anderson Cancer Center

Princess Margaret Cancer Centre

University of Pennsylvania

Michael Pourdehnad is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1999–2024

37

Publications

37

Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.

H. Zhuang, Michael Pourdehnad, E.S. Lambright et al. · PubMed · 2001 · 622 citations

, , +17

The measurement of regional cerebral blood flow during the complex cognitive task of meditation: a preliminary SPECT study

Andrew B. Newberg, Abass Alavi, Michael J. Baime et al. · Psychiatry Research Neuroimaging · 2001 · 491 citations · Full text

, , +12

Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers

Michael Pourdehnad, Morgan Truitt, Imran Siddiqi et al. · Proceedings of the National Academy of Sciences · 2013 · 296 citations · Full text

, , +17

The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants.

H Zhuang, Paulo Schiavom Duarte, Michael Pourdehnad et al. · PubMed · 2001 · 239 citations

, , +17

CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells

Christine Surka, Liqing Jin, Nathan Mbong et al. · Blood · 2020 · 221 citations · Full text

, , +11

1–5 of 37